There's a big kind of murky middle of people where it's not totally clear how big a danger than they're weight poses. So if you think about it, maybe not everyone who qualifies as overweight or obese is necessarily going to be the best candidate for these drugs. There have been studies of this new drug, Guagovi, that show when people quit the drug after a year, the weight comes back for most people.
Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek."
Hosted by Carol Massar and Madison Mills
Hear the show live at 3PM ET on WBBR 1130 AM New York, Bloomberg 106.1 FM Boston, Bloomberg 960 AM San Francisco, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 119, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio.
You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News.
Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno @MadisonMills22 and @BW
See omnystudio.com/listener for privacy information.